GENT, Belgium & FREMONT, Calif.--(BUSINESS WIRE)--ADx NeuroSciences, a wholly owned subsidiary of Fujirebio and a leader in neurodegenerative disease biomarker development, and Alamar Biosciences, a ...

Interest in biomarkers has exploded in recent years, driven by improvements in data collection and analysis, burgeoning interest in personalized medicine, and efforts to increase the success rate for ...

Long-Term Survivorship After Chimeric Antigen Receptor T-Cell Therapy for Hematologic Malignancies The CHAI platform extracted quantitative histomorphologic features from whole-slide images of ...

Klotho Neurosciences, Inc. (NASDAQ:KLTO) announced the launch of a new genomics diagnostics initiative centered on two epigenetics-based tests designed to support its clinical trials and expand ...

Please provide your email address to receive an email when new articles are posted on . Octave Bioscience Inc. has received a $10M grant from the Michael J. Fox Foundation for Parkinson’s Research to ...

First clinical development program in sporadic ALS patients to show potential to restore STATHMIN-2 expression, a statistically significant effect on a neurofilament biomarker, and an overall trend of ...

Dr. Stephen will cover the process of developing and manufacturing reliable Luminex biomarker assays, as well as using those assays to test samples. She will examine the development of Ampersand ...

The Global Cardiac Biomarkers Market is driven by the rising prevalence of cardiovascular diseases, demanding rapid, accurate diagnostics. Opportunities lie in technological advancements in biomarker ...

Q4 2025 earnings call recap: evorpacept/CD47 biomarker data, ASPEN-09 expansion, ALX2004 updates, and $150M raise—read now.

The COVID-19 pandemic and geopolitical conflict in Eastern Europe have done irreparable damage to the underpinnings of the clinical diagnostic industry. These events significantly impacted the supply ...